about
Risk determination and prevention of breast cancerCan diet and lifestyle prevent breast cancer: what is the evidence?Biomarkers of dietary energy restriction in women at increased risk of breast cancer.Evaluation of the current knowledge limitations in breast cancer research: a gap analysisIntermittent energy restriction induces changes in breast gene expression and systemic metabolismCould Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of EvidenceBreast cancer risk feedback to women in the UK NHS breast screening population.Potential Benefits and Harms of Intermittent Energy Restriction and Intermittent Fasting Amongst Obese, Overweight and Normal Weight Subjects-A Narrative Review of Human and Animal Evidence.Can Communicating Personalised Disease Risk Promote Healthy Behaviour Change? A Systematic Review of Systematic Reviews.Recruitment to the "Breast-Activity and Healthy Eating After Diagnosis" (B-AHEAD) Randomized Controlled Trial.Do negative screening test results cause false reassurance? A systematic review.Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK.Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.Development of MR quantified pancreatic fat deposition as a cancer risk biomarker.Intermittent energy restriction for weight loss: Spontaneous reduction of energy intake on unrestricted days.‘For me it's about not feeling like I'm on a diet’: a thematic analysis of women's experiences of an intermittent energy restricted diet to reduce breast cancer riskPsychological impact of providing women with personalised 10-year breast cancer risk estimatesUptake of breast cancer prevention and screening trialsEnergy Balance in Early Breast Cancer Patients Receiving Adjuvant ChemotherapyLifestyle behaviours and health measures of women at increased risk of breast cancer taking chemopreventionData Independent Acquisition Mass Spectrometry Can Identify Circulating Proteins That Predict Future Weight Loss with a Diet and Exercise ProgrammeWhy young women gain weight: A narrative review of influencing factors and possible solutionsYoung adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom)Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trialsPredictors of weight gain in a cohort of premenopausal early breast cancer patients receiving chemotherapyHow do women experience a false-positive test result from breast screening? A systematic review and thematic synthesis of qualitative studiesThe effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trialReply to Comment on "The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trial"Effects of Intermittent Energy Restriction Combined with a Mediterranean Diet on Reducing Visceral Adiposity: A Randomized Active Comparator Pilot Study
P50
Q26991921-F66A5A96-ECF8-4344-B248-BC8B112B15AAQ28081215-DCE76257-616C-4EA2-88DF-8CEBE72C4F40Q33490898-EC77F81A-4A95-4DF4-A449-0F3472FD71A8Q36678664-B953BD2B-571E-4299-92CC-5F1A956425F8Q36945226-1193F9AA-C57B-462B-B4B4-E1D7B342D86CQ37089815-E685D1B7-087D-462D-89D9-8DE221D5C5D6Q37175043-496523EF-8A96-493B-BEB6-1819D1A34B2AQ37727737-82F9C1BF-CEF4-424E-A214-16F4D43250FFQ38746295-77F82135-E9FD-46B0-ADE0-2B63F261C9BEQ38767362-00C86AC1-0213-4760-A1CA-327E1D133CF7Q47953814-646114FD-0A6C-4782-B02F-F9735A7CCFF7Q49249232-B964C8E7-AA1A-4974-A9E4-4B43249363ABQ50654722-3BACA683-C0CE-404D-8086-B2FDB44318ECQ53176084-03FE3A9B-7CDA-4FF6-9304-BCBD8B429D82Q55058947-EE098BAC-D486-478A-80F1-70EC68867536Q57266313-571C9507-904B-40D6-8DD8-E43FB9360959Q57266318-64C5B502-275D-45FB-AB2A-6254AFEABF36Q57266618-6AEDC352-5AD5-4F3D-A2D8-B54F8A3B29FBQ59288837-C82DFBF0-7AAE-420B-8586-FC0563BFEA1BQ64004347-44DFFB0B-BEF6-4DC1-8810-88CD1F4040E0Q64246006-D647BC68-A42E-4633-AA2F-F1C667CE5854Q89500116-EA412BAF-D73B-4A68-8430-769E35F36A53Q90590091-CD040412-6D76-4D04-84C0-BBE3C2334A62Q91650503-F8EF666A-2B18-46C1-8E85-BA64691105B3Q91893966-2E3B02DA-F329-4BC1-B352-4C4FDBAD497EQ92093011-74705B68-21B8-499F-A2E9-79DD55A9B992Q92322479-6FDEB19D-DFAB-4B9B-A370-2E655EAA6022Q92610894-16DBA503-041F-45F0-8B57-DA7645BB6F2EQ92941024-45593FAC-80CF-4728-A596-55BBF1215E84
P50
description
researcher ORCID ID = 0000-0001-9761-3089
@en
wetenschapper
@nl
name
Michelle N Harvie
@ast
Michelle N Harvie
@en
Michelle N Harvie
@nl
type
label
Michelle N Harvie
@ast
Michelle N Harvie
@en
Michelle N Harvie
@nl
prefLabel
Michelle N Harvie
@ast
Michelle N Harvie
@en
Michelle N Harvie
@nl
P21
P31
P496
0000-0001-9761-3089